ELLIOTT SIGAL, M.D., PH.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

ALNYLAM PHARMACEUTICALS, INC.

Filing Date Source Excerpt
2023-04-03 Dr. Sigal possesses extensive experience in the biopharmaceutical industry, including decades of senior leadership and board experience at biopharmaceutical companies.
2025-03-24 Dr. Sigal possesses extensive experience in the biopharmaceutical industry, including decades of senior leadership and board experience at biopharmaceutical companies.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22